Satellite Chemical stock
002648.SZSHZSatellite Chemical Co.,Ltd., Basic MaterialsISIN CNE100001B07
73Score 73 out of 100, Strong
Price and trend
53 / 100
Price history
+27% in one yearThe chart shows daily closes over 15 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 8.5% below it.
Since January 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Sharply down: the price has fallen very quickly lately (RSI 28).
The price is 23% below its 52-week high. Largest decline in 15 years: 66% (June 2015 to September 2015).
Chart figures for advanced users
- SMA 50$3.93
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$3.80
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)28
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$2.44
- The lowest closing price of the last twelve months.
- Resistance$4.54
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Satellite Chemical Co.,Ltd. belongs to the Chemicals (Specialty) industry (China) and, with a market value of $11.72B, is number 28 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $6.89B (up 0.7% year on year) and earnings of $796.12M (down 12.5%).
- For fiscal 2026, analysts expect on average revenue of $8.95B (up 29.9%) and adjusted earnings per share of $0.51 (up 126.2%).
Show more
- MEQIRI Score 73 out of 100 (Strong): rank 48 of 467 in Basic Materials, median 58.
- The P/E is 7.3 (Chemicals (Specialty) median 20.2, own median of recent years 12.5).
- Our model puts fair value at $12.14, with the price 71% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 33.7% a year since 2020, Chemicals (Specialty) median 12.7%.Growth 88
- Modestly valuedP/E 7.3, Chemicals (Specialty) median 20.2, own median 12.5.Valuation 96
- Below fair valuePrice 71% below the fair value of $12.14.Valuation 96
Weaknesses
- DilutionShare count up 13% since 2020.Capital allocation 50
Its standout strengths are valuation and growth.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 72 to 73.
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Significantly undervaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $8.67 and expensive above $20.23 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $14.72 (cash-flow model) and $9.55 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 7.6%. At 8.6% the fair value would be $10.89, at 6.6% it would be $13.96.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (20.2).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 19.9% on the twelve months before. Revenue has grown strongly since 2008, at around 26% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 21%, operating 17%, net 12%. Last 12 months: net 18%.
Debt & balance sheet
latest quarterModerate debt, and interest is adequately covered.
Earnings
- Next earnings
- 30 Mar 2027in 138 days
- Last reported
- 16 Oct 2026EPS reported $0.13 (expected $0.13)in line with expectations
Analyst estimates
Earnings estimates have barely changed since 28 Oct 2026.
- Earnings per share
- $0.51+1.2%
- Revenue
- $8.95B+0.2%
- Earnings per share
- $0.51+0.9%
- Revenue
- $9.41B−0.2%
MEQIRI has stored the estimates since 28 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Satellite Chemical
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 73
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Covestro1COV.DE $13.95B43
- Formosa Plastics1301.TW $13.6B42
- RPM InternationalRPM $13.49B68
- Akzo NobelAKZA.AS $12.11B64
- AlbemarleALB $11.33B51
- Grace Fabric Technology603256.SS $11.14B62
- Evonik IndustriesEVK.DE $10.87B61
- Solstice Advanced MaterialsSOLS $10.56B63
ETFs that hold Satellite Chemical
Held by 43 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Amundi MSCI China A UCITS ETF AccCNAA | 0.20% | 0.35% | €83.52M |
| Xtrackers Harvest CSI300 UCITS ETF 1DRQFI | 0.19% | 0.65% | €251.46M |
| Xtrackers Harvest CSI A500 UCITS ETF 1DAH50 | 0.17% | 0.65% | €10.8M |
Show 5 more
| Amundi MSCI China ESG Selection Extra UCITS ETF AccLCHI | 0.06% | 0.65% | €473.19M |
| HSBC MSCI China UCITS ETFH4ZP | 0.04% | 0.28% | €865.21M |
| UBS MSCI China Universal UCITS ETF USD disUETC | 0.03% | 0.30% | €134.65M |
| Franklin FTSE China UCITS ETFFLXC | 0.03% | 0.19% | €1.3B |
| Xtrackers MSCI Emerging Markets ESG UCITS ETF 1CXZEM | 0.01% | 0.25% | €1.15B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = CN¥6.6707)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 26 Jun 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.